Literature DB >> 27313098

Bullous Pyoderma Gangrenosum in a Patient with Acute Myelogenous Leukemia as a Pathergic Reaction after Bone Marrow Biopsy.

Nur Efe İris1,2, Reyhan Diz-Küçükkaya3, Mutlu Arat3, Zahide Eriş4.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27313098      PMCID: PMC5774376          DOI: 10.4274/tjh.2016.0096

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN: 1300-7777            Impact factor:   1.831


× No keyword cloud information.
A 59-year-old male patient presented with a wound over the sacral region on a bone marrow biopsy puncture that had been present for 3 weeks (Figure 1). There was an ulceration of 6x4 cm with a bullous margin. Bullous pyoderma gangrenosum (PG) was diagnosed by the dermatology consultant. Histopathologic examination of the biopsy specimen from the ulcer showed necrosis with an underlying mixed inflammatory cell infiltration within the dermis extending to the subcutis. Cultures of skin biopsies were negative for bacteria, fungi, and atypical mycobacteria. A bone marrow biopsy showed acute myelogenous leukemia (AML) transformed from myelodysplastic syndrome.
Figure 1

Bone marrow biopsy puncture area with 6x4 cm cribriform ulceration with expanding bullous margin.

PG is an uncommon neutrophilic ulcerative skin disease. In contrast to its name, PG is neither an infectious nor a gangrenous condition. Pathergy is commonly observed, especially after debridement of a lesion [1,2]. In PG there is an excessive inflammatory reaction to trauma of the skin by a needle. In this case there was a pathergic reaction after bone marrow biopsy. Definitive diagnosis requires both clinical recognition and exclusion of infectious or neoplastic disorders [3]. PG is usually associated with an underlying systemic disease [1,4]. Based on clinical morphology, PG is classified into four variants: ulcerative, pustular, bullous, and vegetative [5]. Bullous PG is commonly associated with myeloproliferative diseases [5]. Association with leukemia signifies a poor prognosis [5]. Our patient was in remission for AML, he underwent allogeneic hematopoietic stem cell transplantation, and the PG resolved completely.
  5 in total

1.  A rapidly expanding ulcer. Myelodysplastic syndrome-associated (paraneoplastic) pyoderma gangrenosum.

Authors:  Monika Srivastava; Adrienne Rencic; H Carlos Nousari
Journal:  Arch Dermatol       Date:  2003-04

2.  Bullous pyoderma gangrenosum as the presenting sign of fatal acute myelogenous leukemia.

Authors:  Lindy Peta Fox; Adam S Geyer; Sameera Husain; Marc E Grossman
Journal:  Leuk Lymphoma       Date:  2006-01

3.  Recurrent pyoderma gangrenosum and agnogenic myeloid metaplasia.

Authors:  J P Callen; H V Dubin; C F Gehrke
Journal:  Arch Dermatol       Date:  1977-11

Review 4.  Pyoderma gangrenosum: classification and management.

Authors:  F C Powell; W P Su; H O Perry
Journal:  J Am Acad Dermatol       Date:  1996-03       Impact factor: 11.527

Review 5.  Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions.

Authors:  M L Bennett; J M Jackson; J L Jorizzo; A B Fleischer; W L White; J P Callen
Journal:  Medicine (Baltimore)       Date:  2000-01       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.